| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Department of Research, Boehringer Ingelheim Pharma KG, 88397 Biberach, Germany [T. W., A. W., N. K.]; Institute of Cell Biology and Immunology, University of Stuttgart, 70596 Stuttgart, Germany [K. P.]; and Institut Curie, Centre Universitaire, 91405 Orsay, France [P. G.]
RE repeats encoded (RERE) was identified recently as a protein with high homology to the atrophin-1 protein, which appears to be causal in the hereditary neurodegenerative disorder termed dentatorubral-pallidoluysian atrophy (DRPLA) caused by an abnormal glutamine expansion. We have independently identified RERE in a search for genes localized to the translocation breakpoint region at chromosome 1p36.2 in the neuroblastoma cell line NGP. Here we show that neuroblastoma tumor cell lines display reduced abundance of RERE transcripts. Furthermore, we detected RERE protein mainly in the nucleus, where it colocalizes with the promyelocytic leukemia protein in promyelocytic leukemia oncogenic domains (PODs). Overexpression of RERE recruits a fraction of the proapoptotic protein BAX to PODs. This observation correlates with RERE-induced apoptosis, which occurs in a caspase-dependent manner. These results identify RERE as a novel component of PODs and suggest an important role of RERE in the control of cell survival.
This article has been cited by other articles:
![]() |
R. Hou and N. E. S. Sibinga Atrophin Proteins Interact with the Fat1 Cadherin and Regulate Migration and Orientation in Vascular Smooth Muscle Cells J. Biol. Chem., March 13, 2009; 284(11): 6955 - 6965. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shen, G. Lee, Y. Choe, J. S. Zoltewicz, and A. S. Peterson Functional Architecture of Atrophins J. Biol. Chem., February 16, 2007; 282(7): 5037 - 5044. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wang, H. Rajan, J. L. Pitman, M. McKeown, and C.-C. Tsai Histone deacetylase-associating Atrophin proteins are nuclear receptor corepressors Genes & Dev., March 1, 2006; 20(5): 525 - 530. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Kwekel, L. D. Burgoon, J. W. Burt, J. R. Harkema, and T. R. Zacharewski A cross-species analysis of the rodent uterotrophic program: elucidation of conserved responses and targets of estrogen signaling Physiol Genomics, November 17, 2005; 23(3): 327 - 342. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Kankel, D. M. Duncan, and I. Duncan A Screen for Genes That Interact With the Drosophila Pair-Rule Segmentation Gene fushi tarazu Genetics, September 1, 2004; 168(1): 161 - 180. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Zoltewicz, N. J. Stewart, R. Leung, and A. S. Peterson Atrophin 2 recruits histone deacetylase and is required for the function of multiple signaling centers during mouse embryogenesis Development, January 1, 2004; 131(1): 3 - 14. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. C. Nucifora Jr., L. M. Ellerby, C. L. Wellington, J. D. Wood, W. J. Herring, A. Sawa, M. R. Hayden, V. L. Dawson, T. M. Dawson, and C. A. Ross Nuclear Localization of a Non-caspase Truncation Product of Atrophin-1, with an Expanded Polyglutamine Repeat, Increases Cellular Toxicity J. Biol. Chem., April 4, 2003; 278(15): 13047 - 13055. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |